Results 101 to 110 of about 17,718 (201)

Ranibizumab port delivery system (RPDS): realising long awaited dream of prolonged VEGF suppression [PDF]

, 2019
Ashish Sharma, Nilesh Kumar, Nikulaa Parachuri, Baruch D. Kuppermann, Francesco Bandello, Carl D. Regillo   +5 more
openalex   +1 more source

The Additive Effect of Topical Dorzolamide-Timolol with Intravitreal Ranibizumab Injection in Diabetic Macular Edema

, 2022
Sara Gadwal, Wafaa A. Madbouly, Mona Mansour   +2 more
openalex   +2 more sources

Intravitreal Ranibizumab Injections Significantly Influence Retinal Venous Calibre in Patients With Diabetic Macular Oedema. [PDF]

J Ophthalmol
Chehade LK, Ali N, Sanfilippo PG, Sandhu SS, Lim LL, Wickremasinghe SS.   +5 more
europepmc   +1 more source

The response to ranibizumab therapy after three injections predicts 12-month outcomes in DME in the absence of rescue laser therapy.

, 2016
Joanna Dilley, Simon Taylor
openalex   +1 more source

Intravitreal ranibizumab for persistent diabetic vitreous haemorrhage: a randomised, double‐masked, placebo‐controlled feasibility study. [PDF]

, 2019
Robert Petrarca, Cristina Soare, Roger Wong, Riti Desai, James E. Neffendorf, Andrew Simpson, Timothy L. Jackson   +6 more
openalex   +1 more source

Impact of retinal thickness fluctuations with ranibizumab versus aflibercept in neovascular age-related macular degeneration (SALT): 12-month results from a multicentre, randomised, phase IV trial. [PDF]

Br J Ophthalmol
Agostini HT, Silva R, Holz FG, Larsen M, Altay L, Souied EH, Quiering C, Rose U, Liakopoulos S, SALT study group.   +9 more
europepmc   +1 more source

Residual edema evaluation with ranibizumab 0.5 mg and 2.0 mg formulations for diabetic macular edema (REEF study) [PDF]

, 2015
Dilsher S. Dhoot, Dante J. Pieramici, Ma'an Nasir, Alessandro Castellarin, Steve Couvillion, Robert F. See, Nathan Steinle, M. D. Bennett, Melvin Rabena, Robert L. Avery   +9 more
openalex   +1 more source

Ranibizumab on optic disc perfusion in central retinal vein occlusion. [PDF]

Int J Ophthalmol
Li X, Hao XF, Xie LK, Luo JH, Zhang MJ.
europepmc   +1 more source

Worsening anatomic outcomes following aflibercept for neovascular age-related macular degeneration in eyes previously well controlled with ranibizumab [Corrigendum]

, 2017
Eric Nudleman, Jeremy D. Wolfe, Maria A. Woodward, Yoshihiro Yonekawa, George Williams, T. Hassan   +5 more
openalex   +2 more sources

Trends in Anti-Vascular Endothelial Growth Factor Injections Among Medicare Part B Beneficiaries in 2013-2021 and the Step Therapy Era. [PDF]

J Vitreoretin Dis
Bryan JM, Sheth N, Heiferman MJ.
europepmc   +1 more source